alkenes has been researched along with gefitinib in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, J; Han, S; Jia, Q; Lin, Y; Lv, Y | 1 |
| Li, J; Li, Y; Qian, X; Shan, Y; Wang, G; Xie, Y; Zhang, M; Zhang, X; Zhang, Z | 1 |
2 other study(ies) available for alkenes and gefitinib
| Article | Year |
|---|---|
Dual-mixed/CMC model for screening target components from traditional Chinese medicines simultaneously acting on EGFR & FGFR4 receptors.
Topics: Abietanes; Alkenes; Cell Proliferation; Chromatography, High Pressure Liquid; Drugs, Chinese Herbal; ErbB Receptors; Gefitinib; HEK293 Cells; Humans; Phenanthrenes; Polyphenols; Protein Kinase Inhibitors; Receptor, Fibroblast Growth Factor, Type 4; Salvia miltiorrhiza; Sorafenib; Spectrometry, Mass, Electrospray Ionization | 2019 |
Poly(maleic anhydride-alt-1-octadecene)-based bioadhesive nanovehicles improve oral bioavailability of poor water-soluble gefitinib.
Topics: Administration, Oral; Alkenes; Biological Availability; Gefitinib; Lipids; Maleic Anhydrides; Solubility; Water | 2022 |